103 related articles for article (PubMed ID: 16390781)
1. FEM1A is a candidate gene for polycystic ovary syndrome.
Maher JF; Hines RS; Futterweit W; Crawford S; Lu D; Shen P; Oefner P; Kazi M; Wilson JG; Subauste JS; Cowan BD
Gynecol Endocrinol; 2005 Dec; 21(6):330-5. PubMed ID: 16390781
[TBL] [Abstract][Full Text] [Related]
2. FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.
Goodarzi MO; Maher JF; Cui J; Guo X; Taylor KD; Azziz R
Hum Reprod; 2008 Dec; 23(12):2842-9. PubMed ID: 18757445
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
[TBL] [Abstract][Full Text] [Related]
4. The genetics of the polycystic ovary syndrome.
Urbanek M
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):103-11. PubMed ID: 17237837
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
Kurzrock R; Cohen PR
Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the WNT-4 gene in patients with polycystic ovary syndrome.
Canto P; Söderlund D; Carranza-Lira S; Méndez JP
Gynecol Endocrinol; 2006 Sep; 22(9):484-7. PubMed ID: 17071531
[TBL] [Abstract][Full Text] [Related]
8. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
10. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.
Wood JR; Ho CK; Nelson-Degrave VL; McAllister JM; Strauss JF
J Reprod Immunol; 2004 Aug; 63(1):51-60. PubMed ID: 15284005
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
12. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
Kauffman RP; Baker TE; Baker VM; DiMarino P; Castracane VD
Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
[TBL] [Abstract][Full Text] [Related]
15. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
Ferk P; Teran N; Gersak K
Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
[TBL] [Abstract][Full Text] [Related]
16. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients.
Kenigsberg S; Bentov Y; Chalifa-Caspi V; Potashnik G; Ofir R; Birk OS
Mol Hum Reprod; 2009 Feb; 15(2):89-103. PubMed ID: 19141487
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome.
Kim JJ; Choi YM; Hong MA; Hwang SS; Yoon SH; Chae SJ; Jee BC; Ku SY; Kim JG; Moon SY
Hum Reprod; 2009 May; 24(5):1184-90. PubMed ID: 19218574
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
19. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
20. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
